A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.
Chilengi R, Juma R, Abdallah AM, Bashraheil M, Lodenyo H, Nyakundi P, Anabwani E, Salim A, Mwambingu G, Wenwa E, Jemutai J, Kipkeu C, Oyoo GO, Muchohi SN, Kokwaro G, Niehues T, Lang T, Nzila A.
Chilengi R, et al. Among authors: kokwaro g.
Malar J. 2011 Mar 16;10:63. doi: 10.1186/1475-2875-10-63.
Malar J. 2011.
PMID: 21410944
Free PMC article.
Clinical Trial.